2Rook AH,Vowels BR,Jaworsky C,et al.The immunopathogenesis of cutaneous T-cell lymphoma.Abnormal cytokine production by Sezary T cells.Arch Dermatol,1993,129:486-489.
3Mao X,Orchard G,Lillington DM,et al.Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas.Blood,2003,101:1513-1519.
4Scarisbrick JJ,Woolford AJ,Russell-Jones R,et al.Allelotyping in mycosis fungoides and Sezary syndrome:common regions of allelic loss identified on 9p,10q,and 17p.J Invest Dermatol,117:663.
5Navas IC,Algara P,Mateo M,et al.pl6(INK4a) is selectively silenced in the tumoral progression of mycosis fungoides.Lab Invest,2002,82:123-132.
6Garatti SA,Roscetti E,Trecca D,et al.bcl-1,bcl-2,p53,c-myc,and lyt-10 analysis in cutaneous lymphomas.Recent Results Cancer Res,1995,139:249-261.
7Herrmann JJ,Roenigk HH Jr,Hurria A,et al.Treatment of mycosis fungoides with photochemotherapy (PUVA):long-term follow-up.J Am Acad Dermatol,1995,33(2 Pt 1):234-242.
8Stern RS,Bolshakov S,Nataraj AJ,et al.p53 mutation in nonmelanoma skin cancers occurring in psoralen ultraviolet a-treated patients:evidence for heterogeneity and field cancerization.J Invest Dermatol 2002,119:522-526.
9Diederen PV,van Weelden H,Sanders C J,et al.Narrowband UVB and psoralen-UVA in the treatment of early-stage mycosis fungoides:a retrospective study.J Am Acad Dermatol,2003,48:2159.
10Jones GW,Rosenthal D,Wilson LD.Total skin electron radiation for patients with erythrodermic cutaneous T-cell lymphoma (mycosis fungoides and the Sezary syndrome).Cancer,1999,85:1985-1995.
